文献速递生殖医学

≤6 cm非宫腔扭曲性肌壁间子宫肌瘤对体外受精结局影响的系统评价与Meta分析

The effect of ≤6 cm sized noncavity-distorting intramural fibroids on in vitro fertilization outcomes: a systematic review and meta-analysis.
PubMed 文献 · Fertil Steril · 2023-02-21

该系统评价与Meta分析纳入5项研究,比较≤6 cm非宫腔扭曲性肌壁间子宫肌瘤女性(n=520)与无肌瘤对照(n=1392)的IVF结局。结果显示肌瘤组活产率显著降低(OR 0.48,95%CI 0.36-0.65,3项研究,I²=0,低确定性证据),≤4 cm亚组活产率显著降低而≤2 cm亚组未显著降低,FIGO 3型2-6 cm肌瘤与活产率显著降低相关。

要点

  • ≤6 cm非宫腔扭曲性肌壁间肌瘤者IVF活产率显著低于无肌瘤对照(OR 0.48,95%CI 0.36-0.65)。
  • ≤4 cm亚组活产率显著降低,≤2 cm亚组未显著降低,FIGO 3型2-6 cm肌瘤与活产率显著降低相关。
  • 因研究缺乏,单发与多发肌瘤对IVF结局的影响无法评估。

核心结论

  • 2-6 cm非宫腔扭曲性肌壁间子宫肌瘤对IVF活产率有不良影响,FIGO 3型2-6 cm肌瘤与活产率显著降低相关。
  • 在日常临床实践中对此类小肌瘤女性IVF前提供子宫肌瘤剔除术之前,需要高质量随机对照试验提供确证性证据。

研究设计与样本

  • 系统评价与Meta分析,检索MEDLINE、Embase、Global Health和Cochrane Library数据库自建库至2022年7月1日。
  • 研究组为接受IVF的≤6 cm非宫腔扭曲性肌壁间子宫肌瘤女性(n=520),对照组为无肌瘤女性(n=1392)。
  • 最终纳入5项研究,采用Mantel-Haenszel法计算OR及95%CI,使用RevMan 5.4.1进行统计分析。

主要发现

  • ≤6 cm非宫腔扭曲性肌壁间肌瘤组活产率显著低于无肌瘤对照组(OR 0.48,95%CI 0.36-0.65,3项研究,I²=0,低确定性证据)。
  • ≤4 cm亚组活产率显著降低,≤2 cm亚组未显著降低。
  • FIGO 3型2-6 cm肌瘤与活产率显著降低相关。
  • 因研究缺乏,非宫腔扭曲性肌壁间肌瘤数目(单发 vs 多发)对IVF结局的影响无法评估。

局限性

  • 活产率分析仅纳入3项研究,证据确定性为低。
  • 因研究缺乏,肌瘤数目(单发 vs 多发)对IVF结局的影响无法评估。
  • 作者结论指出需要高质量随机对照试验提供确证性证据。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: The potential detrimental effects of fibroids on natural fecundity and in vitro fertilization (IVF) outcomes may be influenced by their size, location, and number. The impact of small noncavity-distorting intramural fibroids on reproductive outcomes in IVF is still controversial, with conflicting results. OBJECTIVE(S): To determine whether women with noncavity-distorting intramural fibroids of ≤6 cm size have lower live birth rates (LBRs) in IVF than female age-matched controls with no fibroids. DATA SOURCES: MEDLINE, Embase, Global Health, and Cochrane Library databases were searched from inception until July 1, 2022. STUDY SELECTION AND SYNTHESIS: Women undergoing IVF with noncavity-distorting intramural fibroids ≤6 cm constituted the study group (n = 520), whereas women with no fibroid formed the controls (n = 1392). Female age-matched subgroup analyses were performed to evaluate the impact of different cut-offs for size (≤6, ≤4, and ≤2 cm), location (the International Federation of Gynecology and Obstetrics [FIGO] type-3), and the number of fibroids on reproductive outcomes. Mantel-Haenszel odds ratios (ORs) with 95% confidence intervals (CIs) were used for outcome measures. All statistical analyses were performed using RevMan 5.4.1 MAIN OUTCOME MEASURE(S): The primary outcome measure was LBR. Secondary outcome measures were clinical pregnancy, implantation, and miscarriage rates. RESULT(S): After adopting the eligibility criteria, 5 studies were included in the final analysis. Women with ≤6 cm noncavity-distorting intramural fibroids had significantly lower LBRs (OR: 0.48, 95% CI: 0.36-0.65, 3 studies, I2=0; low-certainty evidence) compared with women with no fibroids. A significant reduction in LBRs was noted in ≤4 cm but not in the ≤2 cm subgroups. The FIGO type-3 fibroids of 2-6 cm size were associated with significantly lower LBRs. Owing to a lack of studies, the impact of the number of noncavity-distorting intramural fibroids (single vs. multiple) on IVF outcomes could not be assessed. CONCLUSION(S): We conclude that 2-6 cm sized noncavity-distorting intramural fibroids have a deleterious effect on LBRs in IVF. The presence of FIGO type-3 fibroids of 2-6 cm size is associated with significantly lower LBRs. Conclusive evidence from high-quality randomized controlled trials, the reference standard study design for studies of health care interventions, is needed before myomectomy might be offered in daily clinical practice to women with such small fibroids before undergoing IVF treatment.

来源:Fertil Steril,查看原文。版权归原作者所有。

引用

  1. Erden M, Uyanik E, Polat M, et al. The effect of ≤6 cm sized noncavity-distorting intramural fibroids on in vitro fertilization outcomes: a systematic review and meta-analysis. Fertil Steril. 2023. PMID: 36813123. doi:10.1016/j.fertnstert.2023.02.018

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。